Standard BioTools Inc. (NASDAQ: LAB) will report Q2 2025 financial results on August 11, 2025, after market close. A conference call and webcast will be held at 4:30 p.m. ET on the same day to discuss financial results and operational progress. Access the call at (888) 346-3970 for US callers and (412) 902-4297 for outside US callers.

Standard BioTools Inc. (Nasdaq: LAB) offers next-generation technologies for biomedical researchers, including SomaScan, mass cytometry, and microfluidics. These technologies aid in developing medicines faster, with a focus on oncology, immunology, and immunotherapy. The company collaborates with academic, government, pharmaceutical, and biotechnology labs globally. Learn more at standardbio.com.

Standard BioTools Inc. products are for Research Use Only, not for diagnostic procedures. For investor inquiries, contact Marissa Bych at [email protected]. Details about limited use label license, patent, and license information can be found on the company’s website. ©2025 Standard BioTools Inc. All rights reserved.

Read more at GlobeNewswire: Standard BioTools Schedules Second Quarter Earnings